Rapamycin Press Logo
  • Home
  • Publication ETHICS
  • Editorial Policies
  • SCIENTIFIC INTEGRITY
  • About +
    • Mission
    • Affiliations
    • Conferences
  • Engage +
    • Subscribe
    • Contact
    • Departments
  • News +
    • Press Releases
    • Author Spotlights
    • Blogs
    SUBMIT A MANUSCRIPT
Rapamycin Press Logo
Rapamycin Press LLC dba Impact Journals
  • Home
  • Publication Ethics
  • Editorial Policies
  • SCIENTIFIC INTEGRITY
  • About
    • Mission
    • Affiliations
    • Conferences
  • Engage
    • Subscribe
    • Contact
    • Departments
  • News
    • Press Releases
    • Author Spotlights
    • Blogs
SUBMIT A MANUSCRIPT

top

Search Results for: behind the study

Dr. Amparo Santamaria

Behind the Study: Enhancing Oocyte Activation in Women with Ovarian Failure

July 15, 2025

Dr. Josh Mitteldorf

Behind the Study: Using Methylation Clocks to Evaluate Anti-Aging Interventions

June 19, 2025

Dr. Stefanie Morgan

Behind the Study: Rapamycin’s 1-Year Impact on Healthspan—PEARL Trial Results

June 6, 2025

Paula Cilleros-Holgado

Behind the Study: How Mitochondrial Dysfunction and Iron Buildup Drive Multiple Sclerosis

April 10, 2025

Dr. Moshe Szyf

Behind the Study: EpiAge: NGS-Based ELOVL2 Epigenetic Clock for Biological Age Assessment

February 19, 2025

Dr. Fabienne Hershkowitz Sikron

Behind the Study: Validating Electronic Frailty Index in National Health System

November 26, 2024

Alex Zhavoronkov

Behind the Study: Longevity Biotechnology – AI, Biomarkers & Geroscience for Healthy Aging

November 21, 2024

Samuel Silva

Behind the Study: DLL3, ASC1, TTF-1 & Ki-67 in Precision Medicine for SCLC

November 18, 2024

Behind the Study: Advance Cancer Therapy Using Functional Information

Behind the Study: Advance Cancer Therapy Using Functional Information

November 1, 2024

Dr. R. Craig Herndon from the Department of Radiation Oncology at the Shannon Medical Center in San Angelo, TX, shares a presentation on a recent editorial he authored that was published by Oncoscience in Volume 11, entitled, “Functional information offers individualized adaptive cancer therapies.”

Drs. Mehdi Mollapour, Jennifer Heritz, and Sarah Backe

Behind the Study: Molecular Chaperones & Tumor Suppressor Stability

October 24, 2024

    CONTACT

    TEL:
    1-800-922-0957 (option 5)
    FAX:
    1-716-313-2661
    eFAX:
    1-716-608-1380

    ADDRESS

    6666 East Quaker St., Suite 1
    Orchard Park, NY 14127

    Journals

    • Aging
    • Oncotarget
    • Oncoscience
    • Genes & Cancer

    About

    • Mission
    • Publication Ethics and Malpractice
    • Affiliations
    • Conferences

    Engage

    • Subscribe
    • Contact
    • Departments
    Aging
    Oncotarget
    Oncoscience
    Genes & Cancer
    By using our site you are giving us permission to use cookies. This website collects cookies to deliver a better user experience, and to analyze our website traffic and performance. Personal data is not collected.
    Privacy policy
    Terms of service
    © 2025 Rapamycin Press LLC dba Impact Journals
    Oncotarget ® is a registered trademark of Rapamycin Press LLC
    Impact Journals ® is a registered trademark of Rapamycin Press LLC